A shortage of a drug used to treat immune disorders has forced U.S. hospitals and infusion clinics to ration it or suspend treatment for many patients who use it, according to The Wall Street Journal.
The medicine, immune globulin, is derived from human blood plasma. It is used to help patients with compromised immune systems fight infections. It also treats muscle and nerve disorders.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,